food and drug administration

FDA Names Pazdur Top Drug Regulator

FDA names longtime cancer scientist Pazdur to lead drug center

The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, replacing the former drug director who was recently ousted after an ethics ...

STAT · 4h

Richard Pazdur, longtime cancer regulator, named drug center director at FDA

· 1d · on MSN

FDA taps oncology expert Pazdur as nation’s top drug regulator

· 1d

FDA Names Longtime Cancer Scientist Pazdur to Lead Drug Center

· 1d

F.D.A. Names Agency Veteran to Run Drug Division

· 5h

FDA appoints veteran oncology chief Pazdur to lead drug center

FDA reverses a decades-old warning for hormone therapy

Digest more

· 9h

FDA Lifts Major Warnings on Hormone Replacement Therapy

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

· 1d

FDA will no longer require significant warning label with hormone therapies for menopause

· 1d

FDA to lift warnings on menopause hormone therapy, potentially boosting access

· 1d

FDA Removes Black Box Warning on Hormone Therapy

U.S. health officials have announced the first steps to remove the black box warning on estrogen products prescribed to treat symptoms of menopause.

· 1d

U.S. to drop "black box" warnings on hormone therapy drugs used for menopause

· 1d

FDA to remove ‘black box’ warning from hormone therapy for menopause

4hon MSN

FDA Unveils New Path for Approving Rare Disease Drugs for Just One Person

US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring the promise of gene editing to more people with devastating diseases.Food and Drug Administration Commissioner Marty Makary and Vinay Prasad,

Marijuana Moment

Vance, RFK And Other Top Trump Admin Officials Attend MAHA Summit Featuring Psychedelics Session

Secretary Robert F. Kennedy Jr., Food and Drug Administration (FDA) Commissioner Marty Makary and other top Trump administration officials are attending a “Make America Healthy Again” summit that features a session on the therapeutic potential of psychedelics.

UVA Today

As GLP-1 drugs go mainstream, this expert says health is more than a number on a scale

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump Administration and two major drugmakers announced an agreement to drastically reduce the cost of the drugs for people enrolled in Medicare and Medicaid, as well as for cash buyers.

6don MSN

Trump administration announces deal to lower weight loss drug prices for many Americans

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans.

6don MSN

Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

SeafoodSource

Foreign food inspections plummet following Trump administration layoffs

Foreign food inspections conducted by the U.S. Food and Drug Administration (FDA) have plummeted under U.S. President Donald Trump’s second term, according to an investigation by news outlet ProPublica.

2don MSN

Cancer-causing contaminant in blood pressure pills may point to higher safety risks in older generic drugs

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.

Nationwide Recall Alert: ADHD Drug May Not Dissolve Correctly

The U.S. Food and Drug Administration (FDA) classified the recall as a Class II risk. This indicates that using the product "may cause temporary or medically reversible adverse health consequences," but the probability of serious harm is considered remote.